By Scott Berger Waters Inc
Published in: Cell & Gene
Published on: February 22, 2022
Liquid-chromatography-mass spectrometry (LC-MS) is a critical methodology for accurately characterizing the wide-ranging variability of biologics. This knowledge can be transformed into single multiplexed assays for monitoring attributes across development, manufacturing, and release. LC-MS-based peptide multi-attribute method (MAM) workflows, like those offered by the Waters BioAccord LC-MS System, have been gaining interest across development and commercialization organizations to accomplish this.